Progentec
Oklahoma City, US · Founded 2015 · Delaware corporation · 16 employees on LinkedIn · 1 known investors
Progentec develops diagnostic and digital health solutions for autoimmune disease detection and treatment, including biomarker tests and remote monitoring technologies for clinicians and patients. The company focuses on improving health outcomes for the 25 million Americans living with autoimmune diseases.
Founders & leadership

Investors · 1
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2017
▶$2.5MraisedNov 2018 · 7 investors · BiotechnologyRule 506(c)
- Robert SaundersDirector
- Mohan PurushothamanExecutive Officer, Director
- Sanjiv SharmaExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $75K
- Proceeds to insiders
- $150K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with Progentec for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Progentec do?
- Progentec develops diagnostic and digital health solutions for autoimmune disease detection and treatment, including biomarker tests and remote monitoring technologies for clinicians and patients. The company focuses on improving health outcomes for the 25 million Americans living with autoimmune diseases.
- Who are Progentec's investors?
- Progentec's investors include Plains Ventures.
- How much funding has Progentec raised?
- Progentec has disclosed $2.5M raised across 1 round.
- Where is Progentec headquartered?
- Progentec is headquartered in Oklahoma City, US.

